Results 11 to 20 of about 1,793,389 (302)

Broad-spectrum antiviral agents [PDF]

open access: yesFrontiers in Microbiology, 2015
Development of highly effective, broad-spectrum antiviral agents is the major objective shared by the fields of virology and pharmaceutics. Antiviral drug development has focused on targeting viral entry and replication, as well as modulating cellular ...
Jun-Da eZhu   +3 more
doaj   +2 more sources

Ribonucleases as antiviral agents [PDF]

open access: yesMolecular Biology, 2014
Many ribonucleases (RNases) are able to inhibit the reproduction of viruses in infected cell cultures and laboratory animals, but the molecular mechanisms of their antiviral activity remain unclear. The review discusses the well-known RNases that possess established antiviral effects, including both intracellular RNases (RNase L, MCPIP1 protein, and ...
Ilinskaya O., Mahmud R.
openaire   +6 more sources

Efficacy decrease of antiviral agents when administered to ongoing hepatitis C virus infections in cell culture

open access: yesFrontiers in Microbiology, 2022
We report a quantification of the decrease of effectiveness of antiviral agents directed to hepatitis C virus, when the agents are added during an ongoing infection in cell culture vs. when they are added at the beginning of the infection.
Carlos García-Crespo   +21 more
doaj   +1 more source

Silver Nanoparticles as Potential Antiviral Agents

open access: yesPharmaceutics, 2021
Since the early 1990s, nanotechnology has led to new horizons in nanomedicine, which encompasses all spheres of science including chemistry, material science, biology, and biotechnology.
Zubair Ahmed Ratan   +9 more
doaj   +1 more source

Antiviral Agents: Discovery to Resistance

open access: yesViruses, 2020
In the midst of the SARS-CoV-2/Covid-19 outbreak the need for research into, and development of, antiviral agents is brought into sharp focus worldwide for scientists, governments and the public alike [...]
Catherine S. Adamson
doaj   +1 more source

Incidence of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without antiviral medications: A retrospective study.

open access: yesPLoS ONE, 2023
BackgroundAcute kidney injury is a complication of COVID-19 and is associated with severity. Despite no specific antiviral treatment strategy, lopinavir/ritonavir and remdesivir have been used.
Seyed Majid Mousavi Movahed   +8 more
doaj   +1 more source

Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

open access: yesEmerging Infectious Diseases, 2004
Severe acute respiratory syndrome (SARS) is an infectious disease caused by a newly identified human coronavirus (SARS-CoV). Currently, no effective drug exists to treat SARS-CoV infection.
Emily L.C. Tan   +6 more
doaj   +1 more source

Population-Wide Emergence of Antiviral Resistance during Pandemic Influenza [PDF]

open access: yes, 2008
Background: The emergence of neuraminidase inhibitor resistance has raised concerns about the prudent use of antiviral drugs in response to the next influenza pandemic.
Wu, Jianhong   +13 more
core   +2 more sources

Seven classes of antiviral agents [PDF]

open access: yes, 2022
The viral epidemics and pandemics have stimulated the development of known and the discovery of novel antiviral agents. About a hundred mono- and combination antiviral drugs have been already approved, whereas thousands are in development.
Tenson, Tanel   +9 more
core   +1 more source

Novel activities of safe-in-human broad-spectrum antiviral agents [PDF]

open access: yes, 2018
According to the WHO, there is an urgent need for better control of viral diseases. Re-positioning existing safe-in-human antiviral agents from one viral disease to another could play a pivotal role in this process.
Metelitsa, Natalja   +103 more
core   +1 more source

Home - About - Disclaimer - Privacy